…Covid-19 pandemic – have increased of late. This has created advances in the development of new medicines and our ability to find solutions for unmet medical needs. Offering precision and…
…of damaging or killing the virus. It was one of the first antivirals available on the market during the Covid-19 pandemic and was widely adopted by many countries. Scientists from…
…on the latest industry updates. As we approach another autumn/winter season in the northern hemisphere, Covid-19 vaccines are once again making the headlines, but in the last week we have…
…Reece Armstrong, Editor at DDW. Panelists will discuss the following questions: How has the Covid-19 pandemic influenced the advancement of RNA research? What does the investment landscape look like for…
…generation Covid-19 vaccines clinical trial ICON and the US Biomedical Advanced Research and Development Authority (BARDA) will execute a clinical trial to evaluate the effectiveness of next-generation Covid-19 vaccine candidates….
…Department of Health and Human Services, will execute a clinical trial to evaluate the effectiveness of next-generation Covid-19 vaccine candidates. Next generation Covid-19 vaccines could have the potential to expand…
…the Infection Innovation Consortium (iiCON) at the University of Liverpool, and Reece Armstrong, Editor at DDW. Panelists will discuss the following questions: How has the Covid-19 pandemic influenced the advancement…
…severe neuro-cognitive consequences of Covid-19 (post-Covid or Long Covid), published this study in collaboration with Professor Marion Leboyer from the FondaMental Foundation and Dr Ryad Tamouza, Head Immunologist for the…
…to the Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine. Additional pre-clinical data demonstrate that serum antibodies induced by the updated Covid-19 vaccine, when compared to the Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine, also…
…a mitochondrial activator for long Covid, and the world’s first AI-designed bispecific T cell engager – reflecting the breadth of innovative approaches to disease being employed by researchers across the…
…and neck cancer, an estrogen receptor degrader for breast cancer, a mitochondrial activator for long Covid, and the world’s first AI-designed bispecific T cell engager – reflecting the breadth of…
The US Patent and Trademark Office (USPTO) has granted a patent for Axcella Therapeutics’ long Covid treatment candidate AXA1125. AXA1125 is a novel composition of endogenous metabolic modulators (EMMs) designed…
